ARATANA THERAPEUTICS INC's ticker is PETX and the CUSIP is 03874P101. A total of 104 filers reported holding ARATANA THERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $105,000 | +43.8% | 20,400 | 0.0% | 0.00% | +50.0% |
| Q1 2019 | $73,000 | -41.6% | 20,400 | 0.0% | 0.00% | -60.0% |
| Q4 2018 | $125,000 | +5.0% | 20,400 | 0.0% | 0.01% | +25.0% |
| Q3 2018 | $119,000 | +36.8% | 20,400 | 0.0% | 0.00% | +33.3% |
| Q2 2018 | $87,000 | -3.3% | 20,400 | 0.0% | 0.00% | -25.0% |
| Q1 2018 | $90,000 | -15.9% | 20,400 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $107,000 | -14.4% | 20,400 | 0.0% | 0.00% | -20.0% |
| Q3 2017 | $125,000 | -8.8% | 20,400 | +7.9% | 0.01% | -16.7% |
| Q2 2017 | $137,000 | +37.0% | 18,900 | 0.0% | 0.01% | +20.0% |
| Q1 2017 | $100,000 | -26.5% | 18,900 | 0.0% | 0.01% | -28.6% |
| Q4 2016 | $136,000 | -19.0% | 18,900 | +5.6% | 0.01% | -22.2% |
| Q3 2016 | $168,000 | +48.7% | 17,900 | 0.0% | 0.01% | +50.0% |
| Q2 2016 | $113,000 | +14.1% | 17,900 | 0.0% | 0.01% | 0.0% |
| Q1 2016 | $99,000 | +73.7% | 17,900 | 0.0% | 0.01% | +50.0% |
| Q4 2015 | $57,000 | -38.0% | 17,900 | +64.2% | 0.00% | -33.3% |
| Q3 2015 | $92,000 | – | 10,900 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 5,184,942 | $37,487,000 | 4.55% |
| AWM Investment Company, Inc. | 1,587,620 | $11,478,000 | 2.03% |
| Opaleye Management Inc. | 350,200 | $2,279,000 | 0.95% |
| MPM ASSET MANAGEMENT LLC | 250,000 | $1,808,000 | 0.78% |
| Grandeur Peak Global Advisors, LLC | 538,363 | $3,892,000 | 0.56% |
| GENERAL AMERICAN INVESTORS CO INC | 618,660 | $4,473,000 | 0.45% |
| Redmond Asset Management, LLC | 55,941 | $404,000 | 0.19% |
| EcoR1 Capital, LLC | 100,000 | $723,000 | 0.13% |
| WOODSTOCK CORP | 71,906 | $520,000 | 0.10% |
| CADENCE CAPITAL MANAGEMENT LLC | 165,359 | $1,196,000 | 0.08% |